Endocarditis infecciosa
DOI:
https://doi.org/10.17533/udea.iatreia.v28n4a11Palabras clave:
bacteriemia, endocarditis, insuficiencia cardíaca congestivaResumen
La endocarditis infecciosa es una enfermedad producida por la colonización y proliferación de agentes infecciosos en la superficie endotelial del corazón. Su presentación clínica es variable pues depende de condiciones propias del hospedero, tales como el estado inmunológico, la presencia de material protésico y el uso de drogas endovenosas, y del agente causal. El diagnóstico se establece, usualmente, mediante la suma de elementos como la historia clínica, el examen físico, los hemocultivos, el ecocardiograma y otras ayudas. Presentamos el caso de un hombre adulto que acudió al hospital con un cuadro clínico de fiebre e insuficiencia cardíaca aguda. Se documentó la presencia de soplo sistólico en el foco aórtico y el ecocardiograma reveló insuficiencia valvular grave y una lesión vegetante sobre la válvula aórtica bicúspide. Requirió reemplazo valvular y completó el tratamiento antibiótico, dirigido por la sensibilidad demostrada, luego de hemocultivos positivos para Streptococcus mitis.
Descargas
Citas
(1.) Moreillon P, Que YA. Infective endocarditis. Lancet. 2004 Jan;363(9403):139-49.
(2.) Habib G. Management of infective endocarditis. Heart. 2006 Jan;92(1):124-30.
(3.) Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009 Oct;30(19):2369-413. DOI 10.1093/eurheartj/ehp285.
(4.) Kinsey D, White PD. Fever in congestive heart failure. Arch Intern Med. 1940 Jan;65(1):163-70. DOI 10.1001/archinte.1940.00190070173012.
(5.) Jensen-Urstad K, Svenungsson E, de Faire U, Silveira A, Witztum JL, Hamsten A, et al. Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease. Lupus. 2002;11(11):744-52.
(6.) Reddy G, Chatterjee A, Leon K. Left atrial mural endocarditis secondary to mitral valve jet lesion. Circulation. 2015 Apr;131(17):1529-30. DOI 10.1161/CIRCULATIONAHA.115.015626.
(7.) Fowler VG, Scheld WM, Bayer AS. Cardiovascular infections. In: Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s. Principles and Practice of Infectious Diseases. 8th ed. Elsevier 2015. p. 990-1027.
(8.) Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med. 2013 Apr;368(15):1425-33. DOI 10.1056/NEJMcp1206782. Erratum in: N Engl J Med. 2013 Jun 27;368(26):2536.
(9.) Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med. 1981 Apr;94(4 pt 1):505-18.
(10.) Steckelberg JM, Melton LJ 3rd, Ilstrup DM, Rouse MS, Wilson WR. Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med. 1990 Jun;88(6):582-8.
(11.) Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012 May;59(22):1968-76. DOI 10.1016/j.jacc.2012.02.029.
(12.) Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009 Mar;169(5):463-73. DOI 10.1001/archinternmed.2008.603.
(13.) Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008 Oct;168(19):2095-103. DOI 10.1001/archinte.168.19.2095.
(14.) Richey R, Wray D, Stokes T; Guideline Development Group. Prophylaxis against infective endocarditis: summary of NICE guidance. BMJ. 2008 Apr;336(7647):770-1. DOI 10.1136/bmj.39510.423148.AD.
(15.) Ruotsalainen E, Sammalkorpi K, Laine J, Huotari K, Sarna S, Valtonen V, et al. Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients. BMC Infect Dis. 2006 Sep;6:137.
(16.) Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circula-tion. 2007;116(15):1736-54. DOI 10.1161/CIRCULATIONAHA.106.183095.
(17.) Bashore TM, Cabell C, Fowler V Jr. Update on infective endocarditis. Curr Probl Cardiol. 2006 Apr;31(4):274-352.
(18.) Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2013 Dec;8(12):e82665. DOI 10.1371/journal.pone.0082665. Erratum in: PLoS One. 2014;9(10):e111564.
(19.) Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med. 2007 Dec;147(12):829-35.
(20.) Paterick TE, Paterick TJ, Nishimura RA, Steckelberg JM. Complexity and subtlety of infective endocarditis. Mayo Clin Proc. 2007 May;82(5):615-21.
(21.) Thuny F, Avierinos JF, Tribouilloy C, Giorgi R, Casalta JP, Milandre L, et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J. 2007 May;28(9):1155-61.
(22.) Sonneville R, Mirabel M, Hajage D, Tubach F, Vignon P, Perez P, et al. Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study. Crit Care Med. 2011 Jun;39(6):1474-81. DOI 10.1097/CCM.0b013e3182120b41.
(23.) Dickerman SA, Abrutyn E, Barsic B, Bouza E, Cecchi E, Moreno A, et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J. 2007 Dec;154(6):1086-94.
(24.) Thuny F, Di Salvo G, Belliard O, Avierinos JF, Pergola V, Rosenberg V, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation. 2005 Jul;112(1):69-75. Erratum in: Circulation. 2005 Aug;112(9):e125.
(25.) Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014 Jul;148(1):e1-e132. DOI 10.1016/j.jtcvs.2014.05.014. Erratum in: J Thorac Cardiovasc Surg. 2014 Oct;64(16):1763.
(26.) Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000 Apr;30(4):633-8.
(27.) Raoult D, Casalta JP, Richet H, Khan M, Bernit E, Rovery C, et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol. 2005 Oct;43(10):5238-42.
(28.) Gould FK, Denning DW, Elliott TS, Foweraker J, Perry JD, Prendergast BD, et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2012 Feb;67(2):269-89. DOI 10.1093/jac/dkr450. Erratum in: J Antimicrob Chemother. 2012 May;67(5):1304.
(29.) Sachdev M, Peterson GE, Jollis JG. Imaging techniques for diagnosis of infective endocarditis. Infect Dis Clin North Am. 2002 Jun;16(2):319-37, ix.
(30.) Greaves K, Mou D, Patel A, Celermajer DS. Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis. Heart. 2003 Mar;89(3):273-5.
(31.) Thuny F, Grisoli D, Cautela J, Riberi A, Raoult D, Habib G. Infective endocarditis: prevention, diagnosis, and management. Can J Cardiol. 2014 Sep;30(9):1046-57. DOI 10.1016/j.cjca.2014.03.042.
(32.) Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Circulation. 2015 Jan;131(2):131-40. DOI 10.1161/CIRCULATIONAHA.114.012461.
(33.) Herregods MC, Herijgers P. Early surgery in infective endocarditis with large vegetations significantly reduced mortality compared with conventional treatment. Evid Based Med. 2013 Aug;18(4):145-6. DOI 10.1136/eb-2012-100982.
(34.) Tornos P, Iung B, Permanyer-Miralda G, Baron G, Delahaye F, Gohlke-Bärwolf Ch, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart. 2005 May;91(5):571-5.
(35.) Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011 Nov;306(20):2239-47. DOI 10.1001/jama. 2011. 1701.
(36.) Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, Kapadia S, Lerakis S, Cheema AN, et al. Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry. Circulation. 2015 May;131(18):1566-74. DOI 10.1161/CIRCULATIONAHA.114.014089.
(37.) Amat-Santos IJ, Ribeiro HB, Urena M, Allende R, Houde C, Bédard E, et al. Prosthetic valve endocarditis after transcatheter valve replacement: a systematic review. JACC Cardiovasc Interv. 2015 Feb;8(2):334-46. DOI 10.1016/j.jcin.2014.09.013.
(38.) Martínez-Sellés M, Bouza E, Díez-Villanueva P, Valerio M, Fariñas MC, Muñoz-García AJ, et al. Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation. EuroIntervention. 2015 Feb;10(11). pii: 20140826-07. DOI 10.4244/EIJY15M02_05.
(39.) Anguera I, Miro JM, Evangelista A, Cabell CH, San Roman JA, Vilacosta I, et al. Periannular complications in infective endocarditis involving native aortic valves. Am J Cardiol. 2006 Nov;98(9):1254-60.
(40.) Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001 Jan;32(1):50-62.
(41.) Senior JM, Moncayo A. Endocarditis por Citrobacter. Acta Med Col. 1998;23:309-10.
(42.) Senior JM, Saldarriaga C. Endocarditis infecciosa por Paecilomyces variotii. Biomédica. 2009 Apr-Jun;29(2):177-80.
(43.) Hill EE, Herijgers P, Claus P, Vanderschueren S, Peetermans WE, Herregods MC. Clinical and echocardiographic risk factors for embolism and mortality in infective endocarditis. Eur J Clin Microbiol Infect Dis. 2008 Dec;27(12):1159-64. DOI 10.1007/s10096-008-0572-9.
(44.) Rizzi M, Ravasio V, Carobbio A, Mattucci I, Crapis M, Stellini R, et al. Predicting the occurrence of embolic events: an analysis of 1456 episodes of in-fective endocarditis from the Italian Study on Endocarditis (SEI). BMC Infect Dis. 2014 Apr;14:230. DOI 10.1186/1471-2334-14-230.
(45.) Habib G, Badano L, Tribouilloy C, Vilacosta I, Zamorano JL, Galderisi M, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010 Mar;11(2):202-19. DOI 10.1093/ejechocard/jeq004.
(46.) Di Salvo G, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP, et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol. 2001 Mar;37(4):1069-76.
(47.) Vilacosta I, Graupner C, San Román JA, Sarriá C, Ronderos R, Fernández C, et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol. 2002 May;39(9):1489-95.
(48.) Berdejo J, Shibayama K, Harada K, Tanaka J, Mihara H, Gurudevan SV, et al. Evaluation of vegetation size and its relationship with embolism in infective endocarditis: a real-time 3-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging. 2014 Jan;7(1):149-54. DOI 10.1161/CIRCI-MAGING.113.000938.
(49.) Hubert S, Thuny F, Resseguier N, Giorgi R, Tribouilloy C, Le Dolley Y, et al. Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol. 2013 Oct;62(15):1384-92. DOI 10.1016/j.jacc.2013.07.029.
(50.) Biteker FS, Başaran Ö, Doğan V, Biteker M. What is the optimal timing for surgical treatment of infective endocarditis? Mayo Clin Proc. 2015 Mar;90(3):415. DOI 10.1016/j.mayocp.2014.12.020.
(51.) Gálvez-Acebal J, Almendro-Delia M, Ruiz J, de Alar-cón A, Martínez-Marcos FJ, Reguera JM, et al. Influen-ce of early surgical treatment on the prognosis of left-sided infective endocarditis: a multicenter cohort study. Mayo Clin Proc. 2014 Oct;89(10):1397-405. DOI 10.1016/j.mayocp.2014.06.021.
(52.) Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012 Jun;366(26):2466-73. DOI 10.1056/NEJMoa1112843.
(53.) Patrat-Delon S, Rouxel A, Gacouin A, Revest M, Flécher E, Fouquet O, et al. EuroSCORE II underestimates mortality after cardiac surgery for infective endocarditis. Eur J Cardiothorac Surg. 2015 Jun. pii: ezv223.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2015 Iatreia
Esta obra está bajo una licencia internacional Creative Commons Atribución-CompartirIgual 4.0.
Los artículos publicados en la revista están disponibles para ser utilizados bajo la licencia Creative Commons, específicamente son de Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional.
Los trabajos enviados deben ser inéditos y suministrados exclusivamente a la Revista; se exige al autor que envía sus contribuciones presentar los formatos: presentación de artículo y responsabilidad de autoría completamente diligenciados.
